Consumer: Weighing Pradaxa’s Risks

Despite recent sharp criticism and a $650 million settlement, hundreds of thousands of consumers with atrial fibrillation continue to take the blood thinner.

















via NYT > Fitness & Nutrition http://ift.tt/1p7pOrG